Internal medicine, obesity & weight disorders · Kuwait
We treat obesity as a chronic, treatable disease, with modern non-surgical care and a plan designed for you alone.
Services
Evidence-based care
With modern, non-surgical care and a plan designed for you alone.
About the doctor
A consultant in internal medicine, obesity and weight disorders, a member of the Royal College in London, with a fellowship in obesity and weight disorders from Imperial College London. He treats patients in Kuwait with evidence-based care that starts by understanding why each person gained weight, before any treatment is prescribed.
The aim is lasting health: weight loss that comes with better blood sugar, blood pressure and cholesterol, and better sleep and energy.
How it works
We hear your weight story and review your health history and past treatments.
Body composition and lab tests to find causes and complications.
A clear plan combining nutrition, activity and medication when needed.
Regular visits to adjust the plan and keep the results.
Our goal
Weight loss that comes with better blood sugar, blood pressure, sleep and energy.
Free tool
BMI is your weight in kilograms divided by your height in metres squared. It is a useful starting point; a full diagnosis needs a medical assessment.
For information only; it does not replace a consultation.
Patient stories
“Dr. Alajmi changed how I understand obesity and its effect on my health. I highly recommend him.”
“Thanks to Dr. Alajmi I control my weight much better, and I have kept it off for a long time.”
FAQ
Call or WhatsApp +965 1888 828.
Yes. Obesity is a complex, chronic disease linked to more than 200 health problems, and it can be treated with modern methods under medical supervision.
Modern medicines such as Mounjaro, Ozempic/Wegovy and Saxenda, and the gastric balloon, together with a nutrition and activity plan and regular follow-up. The doctor chooses the best option after an assessment.
Ozempic acts on one hormone, GLP-1, while Mounjaro acts on two, GLP-1 and GIP. Average weight loss in trials was higher with Mounjaro, but the choice depends on each patient.
Usually if your BMI is 30 or more, or 27 or more with a weight-related condition such as diabetes or high blood pressure. The final decision follows a medical assessment.
Contact